Estrella Immunopharma, Inc. ESLA
Set alert
0.64 USD -0.09 -12.27%
At close · Oct 30
0.66 +0.02 +3.24%
After hours · Oct 30, 4:00 PM ET
0.6335 Day range 0.7869
0.314 52-week range 3.05
- YTD
- -59.02%
- 1 year
- -74.93%
- Open
- 0.72
- Prev close
- 0.7287
- Mkt cap
- 27.81M
- Vol
- 165.73K
- Avg vol
- 1.78M
- EPS
- -0.25
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.6335
- High
- 0.7869
- Forward P/E
- 0.00
- Beta
- 0.24
- Short ratio
- 0.07
- Inst. own
- 0.55%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.97534
- 200-d avg
- 1.10
- 1y target
- 0.00
Financial health
Altman Z-Score
-52.49 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -4.5×
FY 2020 5y median -5.2× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B -5.5×
FY 2020 5y median 9.1× FY 2025
P/FCF -32.2×
FY 2020 5y median -32.2× FY 2025
EV/EBITDA -4.3×
FY 2020 5y median -4.9× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -3.1%
FY 2020 5y median -3.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE 126.0%
FY 2020 5y median -157.2% FY 2025
ROIC 126.0%
FY 2020 5y median -51.5% FY 2025
ROA -411.2%
FY 2020 5y median -164.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income -47.7%
FY 2020 FY 2025
EPS (diluted) -45.8%
FY 2020 FY 2025
Free Cash Flow 42.6%
FY 2020 FY 2025
Financial Health
Current Ratio 0.1×
FY 2020 5y median 0.5× FY 2025
Quick Ratio 0.1×
FY 2020 5y median 0.5× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2020 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31